Acquired
Novo Nordisk (Ozempic)
David Rosenthal
And in 2007, so only two years after the CEO made that statement, Novo enters a slightly higher dose version of liraglutide into human trials for weight loss. And why do minds change quickly on this? Like the commercial opportunity here, if you can get approved, if you can get it to work, if it's safe, is unlike anything else the pharma industry has.
0
💬
0
Comments
Log in to comment.
There are no comments yet.